Trial · NCT03331913
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain relief | 4 weeks | Pain relief was defined as ≥50% reduction in Visual Analogue Scale score which is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 1 week | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 2 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 3 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 4 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 5 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 6 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 7 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 8 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 9 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 10 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 11 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | Visual Analogue Scale score | 12 weeks | Visual Analogue Scale score is an 11 point scale from 0 - 10 with 0 being no headache |
| Secondary | The overall response to treatment on the Patient Global Impression of Change | 8 weeks | |
| Other | Safety which is assessed by adverse reactions | 12 weeks | Adverse reactions |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03331913/registered